Vasudevan A - Search Results

1

Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.

Vasudevan A, Tharayil V, Raffals LH, Bruining DH, Becker M, Murad MH, Loftus EV Jr. Vasudevan A, et al. Inflamm Bowel Dis. 2024 Apr 3;30(4):660-670. doi: 10.1093/ibd/izad065. Inflamm Bowel Dis. 2024. PMID: 37071852 Free PMC article.

2

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease.

Vasudevan A, Gibson PR, Van Langenberg DR. Vasudevan A, et al. Inflamm Bowel Dis. 2019 Aug 20;25(9):1462-1473. doi: 10.1093/ibd/izy399. Inflamm Bowel Dis. 2019. PMID: 30689858

3

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.

Vasudevan A, Ip F, Liew D, van Langenberg DR. Vasudevan A, et al. Inflamm Bowel Dis. 2020 Feb 11;26(3):369-379. doi: 10.1093/ibd/izz159. Inflamm Bowel Dis. 2020. PMID: 31532479 Review.

4

Approach to medical therapy in perianal Crohn's disease.

Vasudevan A, Bruining DH, Loftus EV Jr, Faubion W, Ehman EC, Raffals L. Vasudevan A, et al. World J Gastroenterol. 2021 Jul 7;27(25):3693-3704. doi: 10.3748/wjg.v27.i25.3693. World J Gastroenterol. 2021. PMID: 34321838 Free PMC article. Review.

5

Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?

Bohra A, Batt N, Dutt K, Sluka P, Niewiadomski O, Vasudevan A, Van Langenberg DR. Bohra A, et al. Among authors: vasudevan a. Inflamm Bowel Dis. 2024 Mar 27:izae069. doi: 10.1093/ibd/izae069. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38537201

6

Approach to loss of response to advanced therapies in inflammatory bowel disease.

Vootukuru N, Vasudevan A. Vootukuru N, et al. Among authors: vasudevan a. World J Gastroenterol. 2024 Jun 14;30(22):2902-2919. doi: 10.3748/wjg.v30.i22.2902. World J Gastroenterol. 2024. PMID: 38947290 Free PMC article. Review.

7

Examining dietary interventions in Crohn's disease.

Chen L, Srinivasan A, Vasudevan A. Chen L, et al. Among authors: vasudevan a. World J Gastroenterol. 2024 Sep 14;30(34):3868-3874. doi: 10.3748/wjg.v30.i34.3868. World J Gastroenterol. 2024. PMID: 39350785 Free PMC article.

8

Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care.

Vasudevan A, Arachchi A, van Langenberg DR. Vasudevan A, et al. J Crohns Colitis. 2013 Oct;7(9):e367-74. doi: 10.1016/j.crohns.2013.02.012. Epub 2013 Mar 23. J Crohns Colitis. 2013. PMID: 23528836

9

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?

Vasudevan A, Gibson PR, van Langenberg DR. Vasudevan A, et al. World J Gastroenterol. 2017 Sep 21;23(35):6385-6402. doi: 10.3748/wjg.v23.i35.6385. World J Gastroenterol. 2017. PMID: 29085188 Free PMC article. Review.

10

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Nicolaides S, Vasudevan A, Long T, van Langenberg D. Nicolaides S, et al. Among authors: vasudevan a. Intest Res. 2021 Apr;19(2):158-170. doi: 10.5217/ir.2020.00008. Epub 2020 Oct 13. Intest Res. 2021. PMID: 33040518 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters